2025 Contemporary Issues in Heart Failure

After completing this activity, you'll be able to: 

• Apply emerging diagnostic and therapeutic strategies. 
• Manage complex conditions such as inflammatory cardiomyopathies, rejection, and fluid overload. 
• Optimize donor selection, desensitization, and organ preservation. 
• Interpret hemodynamic data to guide care in cardiogenic shock. 
• Navigate UNOS/OPTN and HRSA policies with confidence. 

1. Non-Invasive Methods for Diagnosing Rejection after Heart Transplantation
   Kiran K. Kush, MD, MAS 
    
2. Diagnosis and Treatment of Inflammatory Cardiomyopathies 
   Andrew Rosenbaum, MD 
    
3. Donor Heart Selection
   Palak Shah, MD, MS, FHFSA 
    
4. Approach to Antibodies in Heart Transplantation
   Michelle Kittleson, MD 
    
5. Expanding Heart Transplantation - Methods of Heart Procurement and Preservation 
   Ben Bryner, MD 
    
6. Management of Fluid Overload and Renal Dysfunction in Advanced HF – Part 1
   Jeffrey Testani, MD, MTR 
    
7. Management of Fluid Overload and Renal Dysfunction in Advanced HF – Part 2
   Jeffrey Testani, MD, MTR 
    
8. Desensitization Strategies
   Sean Pinney, MD, MS, FHFSA 
    
9. Understanding UNOS/OPTN and HRSA
   Jennifer Cowger, MD
    
10. Advanced Hemodynamics and Cardiogenic Shock
    Manreet Kanwar, MD 
     
11. Device Selection in STEMI and Non-STEMI Shock
    Shashank Sinha, MD

Perfect for professionals seeking to bridge certification prep with the real-world application of advanced HF knowledge, especially:

Physicians | Fellows & Trainees | Advanced Practice Providers | Nurses | Pharmacists

The Heart Failure Society of America (HFSA) is committed to ensuring balance, independence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24-months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity.  

Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interests have been resolved in accordance with the ACCME Updated Standards for Commercial Support.

The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest: 

• Michelle Kittleson, MD

The following faculty and/or accreditors with ability to control content for this activity have listed the below disclosures: 

• Jennifer Cowger, MD
• Manreet Kanwar, MD 
• Kiran K. Kush, MD, MAS 
• Sean Pinney, MD, MS, FHFSA 
• Andrew Rosenbaum, MD 
• Palak Shah, MD, MS, FHFSA 
• Shashank Sinha, MD
• Nancy Sweitzer, MD, PhD

Off-Label Disclosure 

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 
  
The Heart Failure Society of America designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  
  
This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America.  This activity is approved for a maximum of 5.50 contact hours. 
 
The Heart Failure Society of America is an accredited provider of continuing pharmacy education (CPE). This event is accredited for up to 5.50 contact hours of knowledge-based CPE.  ACPE Universal Activity Numbers (UAN): JA4008267-0000-25-013-H01-P. 

The Heart Failure Society of America has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 
  
This activity is approved for 5.50 contact hours (5.50 CEUs) of general continuing education for health care professionals.  

Learners can claim only the credits hours of the completed sessions listed below.  This denotes their participation in the activity. 

Successful completion of this activity includes the completion of the post-course evaluation.